The University of Chicago Header Logo

Safety of combined ablative radiotherapy and immune checkpoint inhibitors in three phase I trials.

Safety of combined ablative radiotherapy and immune checkpoint inhibitors in three phase I trials. Eur J Cancer. 2024 Sep; 209:114264.

View in: PubMed